Navigation Links
Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss
Date:6/7/2008

t. To reduce this possibility, the dose of sulfonylurea medicine may need to be reduced while using BYETTA. Other common side effects with BYETTA include nausea, vomiting, diarrhea, dizziness, headache, feeling jittery, and acid stomach. Nausea is the most common side effect when first starting BYETTA, but decreases over time in most patients.

If patients experience the following severe and persistent symptoms (alone or in combination): abdominal pain, nausea, vomiting, or diarrhea, they should talk to their healthcare provider because these symptoms could be signs of serious medical conditions. BYETTA may reduce appetite, the amount of food eaten, and body weight. No changes in dose are needed for these side effects. These are not all of the side effects from use of BYETTA. A healthcare provider should be consulted about any side effect that is bothersome or does not go away.

For full prescribing information, visit http://www.BYETTA.com.

About Amylin and Lilly

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first- in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide) injection. Amylin's research and development activities leverage the company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is headquartered in San Diego, California with over 2,000 employees nationwide. Further information about Amylin Pharmaceuticals is available at http://www.amylin.com.

Through a long-standing commitment to diabetes care, Lilly provides patients with breakthrough treatments that enable them to live longer, healthier and fuller lives. Since 1923, Lilly has been the industry leader in pioneering
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. TARGETED GENE DELIVERY IN VIVO: Rexin-G Monotherapy Reveals Significant Biological Activity Without Toxicity in Chemo-Resistant Metastatic Breast Cancer (ASCO 2008)
2. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
3. Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma
4. VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma
5. New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data
6. Ikaria Completes Dosing of Phase 1a Clinical Study for IK-1001 (Sodium Sulfide) for Injection
7. New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma
8. Patients Treated with Risperidone Long-Acting Injection had a Significantly Longer Time to Relapse Compared to Quetiapine in International Clinical Study
9. CorMatrix(R) Announces Intramyocardial Injection of Emulsified ECM Technology(TM) Demonstrates Enhanced Angiogenesis and Improved Cardiac Function in a Preclinical Model
10. Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm
11. Inclusion of Six-Year Overall Survival Data in the Eloxatin(R) (oxaliplatin injection) Prescribing Information Granted FDA Priority Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 2015   Mast Therapeutics, Inc. (NYSE ... molecular adhesion and sealant technology (MAST) platform to ... failure, and arterial disease, today announced that Jack ... of Directors. Mr. Lief made this decision to ... role as President and Chief Executive Officer of ...
(Date:5/28/2015)... Calif. , May 28, 2015 Compassion & ... Committee has approved a bill that would authorize the option ... vote was 5-2. ... (SB 128) , would allow mentally competent adults with six ... medication they could take to painlessly and peacefully end an ...
(Date:5/28/2015)... , May 28, 2015  Transportation ... provider, announces winning the SDCE100 Award for ... & Demand Chain Executive magazine. Transportation ... consumer goods distributor quantify and control supply ... their highly competitive market. Deploying Transportation Insight,s ...
Breaking Medicine Technology:Mast Therapeutics Announces Change In Board Of Directors 2Mast Therapeutics Announces Change In Board Of Directors 3Mast Therapeutics Announces Change In Board Of Directors 4California Committee Sends Medical Aid-in-Dying Bill to Senate Floor 2California Committee Sends Medical Aid-in-Dying Bill to Senate Floor 3Transportation Insight Wins SDCE100 Award for Delivering End-to-End Supply Chain Value 2Transportation Insight Wins SDCE100 Award for Delivering End-to-End Supply Chain Value 3Transportation Insight Wins SDCE100 Award for Delivering End-to-End Supply Chain Value 4
... Aug. 23 Ethicon Endo-Surgery, Inc. (EES) today ... site designed to give surgeons advanced access to ... before they reach full-scale release in the marketplace. ... healthcare partners including surgeons, materials managers and OR ...
... Aug. 23 President Barack Obama was voted the most ... , the nation,s leading weekly healthcare business news magazine. It,s ... of the 100 Most Powerful People in Healthcare. ... the top spot for Obama," said Modern Healthcare ...
Cached Medicine Technology:Ethicon Endo-Surgery Launches EESadvancements.com for Advanced Access to Innovative Solutions 2Obama Named the Most Powerful Person in Healthcare for Second Consecutive Year 2
(Date:5/29/2015)... Shaila Jiwa, a physiotherapist from Burnaby ... stated in a new announcement that patients of urinary ... commonly seen as a tabooed topic to talk about ... like Shaila Jiwa try to encourage people to come ... is a condition that can be classified under two ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 Healthpointe ... consultations with specialists, physical therapy, and injections , ... mid back and/or lower back pain, Healthpointe has ... injections for herniated discs, disc protrusions and other ... , Healthpointe’s team of renowned surgeons are ...
(Date:5/29/2015)... 2015 The report “Muscle Spasm ... on the therapeutic development for Muscle Spasm. Spasms ... the body, leading to many different symptoms and ... new targets and MOAs to produce first-in-class and ... review of Axillary Hyperhidrosis with 19 market data ...
(Date:5/29/2015)... Oaksterdam University, the first cannabis college in America, will ... popular and highly demanded Basic and Advanced Classic Seminars ... to 5:30 pm each day. Certification is available upon completion of ... held on June 14 from 12:00 pm to 6:00 pm. Both ... Plaza Hotel & Casino in downtown Las Vegas. , ...
(Date:5/29/2015)... Texas (PRWEB) May 29, 2015 ... professional and in-depth study on the current state ... the report provides key statistics on the state ... of guidance and direction for companies and individuals ... basic overview of the industry including definitions, classifications, ...
Breaking Medicine News(10 mins):Health News:Patients of Urinary Incontinence Should Not "Hide And Suffer," States Physiotherapist from Burnaby Physiotherapy Clinic 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 3Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Oaksterdam University to Host Educational Cannabis Seminars and Job Fair in Las Vegas June 12 to 15; Training For Those Wanting To Work in Legal Cannabis Industry 2Health News:Oaksterdam University to Host Educational Cannabis Seminars and Job Fair in Las Vegas June 12 to 15; Training For Those Wanting To Work in Legal Cannabis Industry 3Health News:Allopurinol Industry (Global, China) 2015 Research Analysis and 2020 Forecasts 2
... human body starts on its immunity system to fight ... the parasitic infections are fought by the human immunity ... Yale School of Medicine had identified a molecule that ... the infections caused by the parasite. ,A parasite ...
... bad news for married women. The strain of such a ... especially that of a heart condition. ,Researchers from Boston ... men and 1913 women to find out how far the ... conditions of the spouses. The researchers had tracked the life ...
... peppermint or cinnamon could make the drivers of motor vehicles ... time makes the drivers of the vehicle angry, fatigued and ... the study under the conditions of three different types of ... added to the air inside the vehicle with the help ...
... through mosquito bites, among other things, did not had a ... Medicine scientists have shown a successful treatment on mice suffering ... antibody that can successfully fight the virus. The antibody is ... this virus and in turn never get affected by the ...
... to cure people suffering from hay fever by teaching them ... for curing allergic reactions. 79 patients of an average age ... grass or pollen were taken in the study. All these ... two years. Random parallel group was used as control for ...
... the addicts find it hard to break the habit formation. ... be that drugs affect the mechanism of the brain and ... like eating and fulfilling of other need, physiological or psychosocial. ... a surgical procedure by which a cutis made to damage ...
Cached Medicine News:
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: